Investigational drug 0653-062
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational drug 0653-062, covering 2024-08-15 to 2024-08-15. Get the full timeline:
Most recent: Clinical Trial Update: An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED) [Phase 3]